PSP Research »

Compass Pathways shares owned by PSP Research

Quarter-by-quarter ownership of Compass Pathways (CMPS) shares owned by PSP Research from 13F filings

Historical chart of PSP Research investment in Compass Pathways

Tip: Access up to 7 years of quarterly data

All positions including Compass Pathways held by PSP Research consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Compass Pathways by PSP Research

Quarter filed Position value Share count Share price at filing
2026-03-31 $393k 71k 5.53

More positions owned by PSP Research

Ishares Tr 0-3 Mnth Treasry (SGOV)
Spdr Series Trust State Street Spd (XBI)
Sera Prognostics Class A Com (SERA)
Definium Therapeutics Com Shs (DFTX)
Tyra Biosciences (TYRA)
Ascendis Pharma A/s Sponsored Adr (ASND)
Pharvaris N V (PHVS)
Cytokinetics Com New (CYTK)
Royalty Pharma Shs Class A (RPRX)
Kymera Therapeutics (KYMR)
Halozyme Therapeutics (HALO)
Exelixis (EXEL)
Disc Medicine (IRON)
Ionis Pharmaceuticals (IONS)
Agios Pharmaceuticals (AGIO)

View all positions for PSP Research

Top funds holding Compass Pathways

Rtw Investments
Deep Track Capital
GMT Capital Corp
ARK Investment Management
UBS Group
Two Sigma Investments
Susquehanna International
Leucadia National Corporation
Eagle Health Investments
D. E. Shaw & Co
Millennium Management
Aisling Capital Management
Ally Bridge Group
Siren
Renaissance Technologies

View all funds holding Compass Pathways